|
Media Releases |
Financial Reports |
Presen-tations |
|
07/30/2008
|
 |
|
|
| Lonza receives United States EPA registration for several formulations to effectively inactivate H5N1 “bird flu” virus |
Basel / Allendale, 30 July 2008 – Lonza announces the successful testing and registra-tion with the United States Environmental Protection Agency (EPA) of several formula-tions to effectively inactivate the H5N1 “bird flu” virus, also known as avian influenza A (H5N1) that has spread across Asia and Europe.
The H5N1 virus is transmitted primarily through contact with surfaces and materials that have been contaminated by infected birds. Lonza’s formulations, used to clean, sanitize and disinfect hard non-porous surfaces, were shown to inactivate the virus, precluding its spread.
As one of the first companies to obtain EPA approval to make claims against the H5N1 “bird flu” virus, Lonza continues to lead the way in meeting the market’s need for disin-fectants that are proven effective against dangerous pathogens, such as H5N1.
13 of Lonza’s U.S. registrations now have this important claim.
About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Bio-pharmaceuticals are one of the key growth drivers of the pharmaceutical and biotech-nology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SWX Swiss Ex-change. In 2007, Lonza had sales of CHF 2.87 billion. Further information can be found at www.lonza.com.
###
For further Information:
Lonza Group:
Head Corporate Communications
Janet White
Tel +41 61 316 8566
Fax +41 61 316 9566
janet.white@lonza.com
Lonza Group:
Media Relations
Dominik Werner
Tel +41 61 316 8798
Fax +41 61 316 9798
dominik.werner@lonza.com
Lonza America, Inc.
Corporate Communications Sr. Manager
Melanie Disa
Tel +1 201 316 9413
Fax +1 201 696 3533
melanie.disa@lonza.com
|
|
|
